Study guide

5.3 Hemostasis & Blood Coagulation

PA-CAT Physician Assistant College Admission Test

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 PA-CAT Exam Facts & Overview 1.2 Exam Structure & the Nine-Subject Blueprint 1.3 Registration, Scheduling & Test Day 1.4 Scoring, Transcripts & Study Strategy

2 Chapter 2: Anatomy — Back & Abdomen

2.1 Curvatures of the Vertebral Column 2.2 The Vertebrae 2.3 Spinal Cord and Spinal Nerves 2.4 The Anterior Abdominal Wall 2.5 The Spleen, Esophagus & Stomach 2.6 Intestines, Pancreas, Liver, Biliary Ducts, Hepatic Circulation & Kidney/Ureters

3 Chapter 3: Anatomy — Head, Pelvis & Perineum

3.1 The Skull 3.2 The Face & The Ear 3.3 The Cranial Nerves 3.4 The Bony Pelvis 3.5 The Pelvic Viscera 3.6 Male & Female Perineum and Reproductive Organs

4 Chapter 4: Anatomy — Thorax & Limbs

4.1 Mediastinum & Thoracic Skeletal/Muscular Components 4.2 Lungs, Trachea, Bronchi & Pericardium 4.3 The Heart & Great Vessels 4.4 Pectoral Girdle, Axilla & Brachial Plexus 4.5 Arm, Forearm, Wrist & Hand 4.6 Hip, Thigh, Gluteal Region, Leg, Joints & Foot

5 Chapter 5: Physiology — Cell, Blood & Circulation

5.1 Functions of the Cellular Organelles 5.2 Translation & Transcription 5.3 Hemostasis & Blood Coagulation 5.4 Basics of Flow, Pressure & Resistance 5.5 Microcirculation & Mechanisms of Blood Flow Control 5.6 Cardiac Output, Venous Return & the Lymphatic System 5.7 Coronary Blood Flow

6 Chapter 6: Physiology — Endocrine, GI & Membrane

6.1 Hypothalamus & Pituitary Hormones 6.2 Thyroid & Parathyroid Hormones 6.3 Endocrine & Adrenocortical Hormones 6.4 GI Motility, Secretion, Digestion & Absorption 6.5 Diffusion, Osmosis & Membrane Transport 6.6 Membrane Potential & the Action Potential 6.7 Muscular Contraction & Carbohydrate/Protein/Lipid Metabolism

7 Chapter 7: Physiology — Nervous & Renal

7.1 Nerve Physiology, Conduction & Transmission 7.2 Somatic Sensations, Motor/Cerebral Circuits & the Autonomic Nervous System 7.3 Fluid Balance, Glomerular Filtration & Tubular Reabsorption/Secretion 7.4 Renal Ion & Acid-Base Regulation

8 Chapter 8: Physiology — Respiratory, Reproduction, Heart & Senses

8.1 Pulmonary Ventilation, Gas Exchange & Pulmonary Circulation/Edema 8.2 O2/CO2 Transport & Regulation of Respiration 8.3 Reproduction: Mitosis/Meiosis, Gametogenesis, Pregnancy & Fetal Physiology 8.4 Heart Structure, Cardiac Cycle, Electrical Activity, Heart Defects & Special Senses

9 Chapter 9: Chemistry — Acids, Atoms, Bonding & Gases

9.1 Brønsted-Lowry Acids/Bases, Measuring Acidity & Strengths 9.2 Atomic Theory, Ions & Molecules 9.3 Chemical Bonding & VSEPR Molecular Geometry 9.4 Balancing, Solubility Rules & Types of Reactions 9.5 Oxidation, Reduction & Electrochemistry 9.6 Gas Laws, Dalton's Partial Pressures & Ideal vs Real Gases

10 Chapter 10: Chemistry — Liquids, Stoichiometry, Thermochemistry & Organic I

10.1 Colligative Properties & Factors Affecting Solubility 10.2 Stoichiometry: Conservation of Matter/Energy & Reactant/Product Calculations 10.3 Thermochemistry & Energy in Chemical Changes 10.4 Alkanes & Cycloalkanes 10.5 Bond Properties & Resonance 10.6 Hybridization/LCAO & Stereochemistry

11 Chapter 11: Chemistry — Spectroscopy & Application

11.1 Spectroscopy 11.2 Acid-Base Titrations & Buffer Systems 11.3 Limiting-Reactant & Percent-Yield Calculations 11.4 Electrochemical Cells & Redox Applications 11.5 Organic Reactions & Functional-Group Reactivity 11.6 Spectroscopic Structure Determination

12 Chapter 12: General Biology — Bioenergetics, Cells & Respiration

12.1 Enzymes, Metabolism, Energy & ATP 12.2 Hydrogen/Electron Carriers & Thermodynamics/Free Energy 12.3 Genome Mapping, Characterizing & Sequencing (Biotechnology) 12.4 Cell Structures, Membranous Organelles & Cell Theory 12.5 Eukaryotic Cell Reproduction & Stages of Meiosis 12.6 Cellular Respiration & Fermentation

13 Chapter 13: General Biology — Transport, Building Blocks & Molecules

13.1 Diffusion/Osmosis, Facilitated & Active Transport, Pinocytosis/Phagocytosis 13.2 Chemical Building Blocks: Proteins, Carbohydrates, Carbon, Nucleic Acids & Lipids 13.3 Water, Organization of Matter & Acids/Bases/Salts 13.4 Biological Molecules: DNA Structure, Replication & Repair 13.5 Gene Expression: Regulation, RNA & Protein Degradation

14 Chapter 14: General Biology — RNA, Structure & Signaling

14.1 Types of RNA, tRNA & Ribosomes 14.2 Pre-mRNA Splicing & Eukaryotic Transcription 14.3 Signal Transduction & Intracellular Communication 14.4 Receptor Types & Intracellular Receptors 14.5 G Protein-Coupled Receptor & Receptor Kinase Signaling

15 Chapter 15: Microbiology — Bacteria

15.1 Intracellular Bacteria 15.2 Gram-Positive Cocci & Rods 15.3 Acid-Fast Bacteria 15.4 Gram-Negative Cocci/Coccobacilli & Fermentative/Nonfermenting Rods 15.5 Anaerobic & Spiral-Shaped Bacteria 15.6 Bacterial Role in Disease 15.7 Viruses: HIV & Human Herpesvirus

16 Chapter 16: Microbiology — Viruses, Fungi, Parasites & Host Interaction

16.1 Respiratory, Hepatitis & Gastrointestinal Viruses + Viral Role in Disease 16.2 Fungal Classification, Opportunistic & Cutaneous/Subcutaneous Fungi 16.3 Systemic Dimorphic Fungi 16.4 Parasites: Protozoa & Helminths (Trematodes, Nematodes, Cestodes) 16.5 Parasite Classification & Arthropods 16.6 Principles of Disease, Epidemiology & Microbial Pathogenicity 16.7 Innate/Adaptive Immunity, Pathology/Infection/Disease, Microorganisms & Human Disease, Environmental Microbiology

17 Chapter 17: Genetics — Molecular Structure & Patterns of Inheritance

17.1 Molecular Structure of DNA & RNA 17.2 Chromosome Organization & DNA Replication 17.3 Chromosome Transmission During Cell Division & Sexual Reproduction 17.4 Mendelian & Non-Mendelian Inheritance 17.5 Genetic Linkage & Mapping in Eukaryotes 17.6 Genetic Transfer & Mapping in Bacteria and Bacteriophages

18 Chapter 18: Genetics — Genes, Mutation, Technologies & Medical Genetics

18.1 Molecular Properties of Genes & the Central Dogma 18.2 Mutation: Types & Consequences 18.3 Recombinant DNA & Genetic Technologies 18.4 Gene Regulation in Prokaryotes & Eukaryotes 18.5 Medical Genetics: Mendelian/Chromosomal/Multifactorial Disorders & Screening 18.6 Cancer Genetics 18.7 Population, Developmental & Quantitative Genetics

19 Chapter 19: Behavioral Sciences — Biological Bases of Behavior & Psychology

19.1 Behavioral Neuroscience: Neuroanatomy & Function 19.2 Sensation & Movement 19.3 States of Consciousness 19.4 Learning & Memory 19.5 Cognition, Language & Intelligence 19.6 Psychology: Schools, Development & Personality

20 Chapter 20: Behavioral Sciences — Stress, Research Methods, Sociocultural & Psychological Disorders

20.1 Health, Stress & Coping 20.2 Psychological Research Methods 20.3 Sociocultural Identity & Development 20.4 Psychological Disorders 20.5 Treatment of Psychological Disorders 20.6 Applied & Lifespan Behavioral Science

21 Chapter 21: Biochemistry — Metabolism, Enzymes & Proteins

21.1 Enzymes: Kinetics & Regulation 21.2 Carbohydrate Metabolism 21.3 TCA Cycle, Electron Transport & Oxidative Phosphorylation 21.4 Lipid Metabolism 21.5 Amino Acid & Nitrogen Metabolism + Protein Structure

22 Chapter 22: Biochemistry — Nucleic Acids, Hormones & Lipids

22.1 Nucleic Acids & Nucleotide Biochemistry 22.2 Hormone Biochemistry & Second-Messenger Systems 22.3 Vitamins & Minerals 22.4 Lipid Structure, Membranes & Transport 22.5 Tissue-Specific Biochemistry & Metabolic Integration

23 Chapter 23: Statistics — Anticipating Patterns & Exploring Data

23.1 Exploring & Describing Data 23.2 Probability 23.3 Random Variables & Probability Distributions 23.4 Sampling Distributions & Simulations

24 Chapter 24: Statistics — Sampling, Experimentation & Statistical Inference

24.1 Sampling, Experimentation & Data Collection 24.2 Confidence Intervals 24.3 Hypothesis Testing 24.4 Inference for Comparisons, Chi-Square & Regression

5.3 Hemostasis & Blood Coagulation

Key Takeaways Explain This Topic AI

Primary hemostasis forms a platelet plug through adhesion (via von Willebrand factor), activation, and aggregation.

Secondary hemostasis is the coagulation cascade: intrinsic (XII→XI→IX→VIII), extrinsic (VII), and common (X→II→I) pathways produce fibrin.

Fibrinolysis dissolves clots via plasmin, generated from plasminogen by tissue plasminogen activator (tPA).

Vitamin K is required for synthesis of factors II, VII, IX, and X (and proteins C and S); warfarin inhibits vitamin K epoxide reductase.

Disorders include hemophilia A (factor VIII), hemophilia B (factor IX), von Willebrand disease (vWF), and DIC (widespread consumption).

Last updated: August 2026

Overview of Hemostasis

Quick Answer: Hemostasis has two phases: primary (platelet plug) and secondary (coagulation cascade forming fibrin). A third process, fibrinolysis , removes the clot once healing begins. The PA-CAT Bulletin of Information, rev. 20240815, includes "Blood and Clotting" in the Physiology blueprint.

Primary Hemostasis: The Platelet Plug

Vascular injury exposes subendothelial collagen and von Willebrand factor (vWF) . Platelets adhere via the glycoprotein Ib-IX-V complex binding vWF, and via GPVI binding collagen. Adhesion triggers platelet activation , which causes:

Shape change (discoid → stellate, via cytoskeletal reorganization).

Degranulation — α-granules release vWF, fibrinogen, factor V; dense granules release ADP, serotonin, calcium .

Thromboxane A₂ (TXA₂) synthesis from arachidonic acid via cyclooxygenase (COX) — aspirin irreversibly inhibits COX-1 in platelets.

GPIIb/IIIa receptor activation — binds fibrinogen, linking platelets into a plug ( aggregation ).

Defects in primary hemostasis cause mucocutaneous bleeding (petechiae, epistaxis, gum bleeding). Von Willebrand disease is the most common inherited bleeding disorder; Glanzmann thrombasthenia is GPIIb/IIIa deficiency; Bernard-Soulier syndrome is GPIb deficiency.

Secondary Hemostasis: The Coagulation Cascade

The cascade is a chain of serine protease zymogens activated by limited proteolysis, amplifying the signal to generate thrombin (factor IIa) , which converts fibrinogen (factor I) to fibrin (factor Ia) . Factor XIIIa then cross-links fibrin for stability.

Intrinsic pathway (contact activation; assessed by aPTT ):

XII → XIIa → XI → XIa → IX → IXa (with VIIIa as cofactor) → X → Xa

Extrinsic pathway (tissue factor; assessed by PT ):

Tissue factor (thromboplastin) + VIIa → X → Xa

Common pathway (assessed by both PT and aPTT):

Xa (with Va cofactor, on phospholipid surface) → prothrombin (II) → thrombin (IIa) → fibrinogen (I) → fibrin (Ia)

Most coagulation factors are synthesized in the liver . Factors II, VII, IX, X (and the anticoagulants protein C and protein S ) require vitamin K as a cofactor for γ-carboxylation, which allows them to bind calcium and anchor to phospholipid surfaces. Warfarin inhibits vitamin K epoxide reductase , blocking this recycling; factor VII has the shortest half-life, so PT (INR) rises first.

Laboratory Tests

  • Test Measures Pathway
  • PT / INR Extrinsic + common VII, X, V, II, I
  • aPTT Intrinsic + common XII, XI, IX, VIII, X, V, II, I
  • Bleeding time Primary hemostasis Platelet function
  • Thrombin time Fibrinogen → fibrin conversion Fibrinogen quality
  • D-dimer Cross-linked fibrin degradation Fibrinolysis / clot presence
  • Fibrinolysis

Once the vessel heals, the clot must be removed. Tissue plasminogen activator (tPA) converts plasminogen to plasmin , which degrades fibrin into D-dimer and other fragments. α₂-antiplasmin limits plasmin activity. Therapeutic tPA (alteplase) is used in acute ischemic stroke and myocardial infarction; it must be given within defined windows (e.g., 3–4.5 hours for stroke).

Anticoagulant and Antiplatelet Drugs

Heparin potentiates antithrombin III , which inactivates thrombin and factor Xa. Low-molecular-weight heparins (enoxaparin) preferentially inhibit Xa.

Warfarin inhibits vitamin K epoxide reductase (oral, delayed onset).

Direct oral anticoagulants (DOACs) — dabigatran (direct thrombin inhibitor), rivaroxaban/apixaban (direct Xa inhibitors).

Aspirin irreversibly inhibits COX-1, blocking TXA₂.

Clopidogrel inhibits the P2Y₁₂ ADP receptor.

Abciximab blocks GPIIb/IIIa.

Clinical Bleeding Disorders

  • Disorder Defect Lab Pattern
  • Hemophilia A Factor VIII deficiency ↑ aPTT, normal PT
  • Hemophilia B Factor IX deficiency ↑ aPTT, normal PT
  • Von Willebrand disease vWF deficiency (qualitative or quantitative) ↑ bleeding time, may ↑ aPTT
  • DIC Widespread activation consuming factors and platelets ↑ PT, ↑ aPTT, ↓ platelets, ↑ D-dimer
  • Liver disease Reduced factor synthesis (all except VIII) ↑ PT, ↑ aPTT
  • Vitamin K deficiency Reduced II, VII, IX, X ↑ PT early, ↑ aPTT late

Hemophilia causes deep tissue and joint bleeding (hemarthrosis), unlike the mucocutaneous pattern of platelet disorders — a classic PA-CAT-style distinction.

Regulation and Inhibitors

The cascade is held in check by natural anticoagulants: antithrombin III (inhibits thrombin, Xa, IXa), protein C and protein S (inactivate factors Va and VIIIa), and tissue factor pathway inhibitor (TFPI) . Protein C deficiency or factor V Leiden (resistant to activated protein C) causes thrombophilia — increased risk of venous thromboembolism. This regulation explains why clots form only at injury sites and not throughout the vasculature.

Thrombin's Dual Role: Procoagulant and Anticoagulant Functions via Thrombomodulin

A recurring PA-CAT physiology trap treats thrombin purely as a procoagulant enzyme that converts fibrinogen to fibrin. In reality, thrombin is a bifunctional switch whose downstream effect depends on which receptor and cofactor it encounters. When thrombin binds thrombomodulin on intact endothelial cells, its active site is reoriented so that it no longer cleaves fibrinogen or activates platelets. Instead, the thrombin-thrombomodulin complex activates protein C , which complexes with endothelial protein C receptor and protein S to proteolytically inactivate factors Va and VIIIa on the same phospholipid surface where the common and intrinsic tenase complexes assemble. This is why protein C deficiency and factor V Leiden (a factor V variant resistant to activated protein C cleavage) produce thrombophilia rather than bleeding: the natural brake on cofactor amplification is lost.

The clinical implication students often miss is that warfarin initiation transiently worsens thrombosis risk . Because protein C has a short half-life similar to factor VII, the anticoagulant protein C falls early while procoagulant factors II, IX, and X decline more slowly. This 'procoagulant window' explains why bridging with heparin is required in patients starting warfarin for acute thrombosis, and it is the mechanism behind warfarin-induced skin necrosis in undiagnosed protein C deficiency.

Thrombin Actions Sorted by Target

  • Thrombin target Location Effect Net result
  • Fibrinogen (factor I) Plasma Cleaves fibrinopeptides A and B Procoagulant (fibrin mesh)
  • Factor V, VIII, XI, XIII Plasma/surface Cofactor and zymogen activation Procoagulant (amplification)
  • PAR-1 and PAR-4 on platelets Platelet membrane Platelet activation and aggregation Procoagulant (plug growth)

Thrombomodulin Intact endothelium Binds thrombin, shifts active site Anticoagulant (blocks fibrinogen cleavage)

Protein C (via thrombomodulin) Endothelial surface Generates activated protein C Anticoagulant (degrades Va and VIIIa)

This dual-role framework resolves a classic exam question: why does a single enzyme both build and dismantle the cascade? The answer is location, cofactor availability, and receptor context, not enzyme identity alone.

Loading diagram...